Chao Feng

机构：Harbin Medical University, Jilin University, Second Affiliated Hospital of Harbin Medical University · ORCID：0000-0003-3259-562X

发表论文 98 篇 · 总被引 2153 次 · h-index 25

代表论文

• NAD+ metabolism-based immunoregulation and therapeutic potential (2023 · Cell & Bioscience · 被引 49)
• Nicotinamide phosphoribosyltransferase in NAD+ metabolism: physiological and pathophysiological implications (2025 · Cell Death Discovery · 被引 30)
• NAD+ salvage governs the immunosuppressive capacity of mesenchymal stem cells (2023 · Cellular and Molecular Immunology · 被引 21)
• IL4I1-catalyzed tryptophan metabolites mediate the anti-inflammatory function of cytokine-primed human muscle stem cells (2023 · Cell Death Discovery · 被引 19)
• Hippo Pathway Activation in Aged Mesenchymal Stem Cells Contributes to the Dysregulation of Hepatic Inflammation in Aged Mice (2023 · Advanced Science · 被引 13)
• Mesenchymal stromal cells confer breast cancer doxorubicin resistance by producing hyaluronan (2023 · Oncogene · 被引 11)